Allergy Therapeutics Plc. financial statements, including revenue, expenses, profit, and loss
The total revenue of AGYTF for the last semiannual is 42.74 M USD, and it's 71.03% higher compared to the previous semiannual. The net income of H1 24 is -19.92 M USD.